SCHEMBL13617064

SCHEMBL13617064

CN1CCC(n2ncc3c(Oc4cccnc4)ncnc32)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.48
HRH4 Q9H3N8 1/20 0.43
MAP4K4 O95819 1/20 0.41
NUDT14 O95848 1/20 0.41
BTK Q06187 1/20 0.41
NUDT5 Q9UKK9 1/20 0.41
SLC2A1 P11166 1/20 0.40
SLC2A2 P11168 1/20 0.40
SLC2A3 P11169 1/20 0.40
CHRNA1 P02708 1/20 0.39
CHRNB1 P11230 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA4 P43681 1/20 0.39
CHRNB3 Q05901 1/20 0.39
PIK3CD O00329 1/20 0.38
PDE9A O76083 1/20 0.38
AXL P30530 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13617063 0.89 CYP3A4 (0.53) CYP3A4HRH4MAP4K4NUDT14BTK
SCHEMBL4351830 0.86 CYP3A4 (0.54) CYP3A4MAP4K4BTKFLT3
SCHEMBL1128413 0.83 CYP3A4 (0.72) CYP3A4
SCHEMBL1128417 0.75 CYP3A4 (0.60) CYP3A4BTKSLC2A1SLC2A2SLC2A3
SCHEMBL1128724 0.72 CYP3A4 (0.61) CYP3A4
SCHEMBL1128336 0.72 CYP3A4 (0.79) CYP3A4
SCHEMBL23579979 0.71 ALOX15 (0.46) CYP3A4NUDT14BTKNUDT5SLC2A1
SCHEMBL13762805 0.71 ALOX15 (0.46) CYP3A4BTKSLC2A1SLC2A2SLC2A3
SCHEMBL13762806 0.71 PI4KA (0.54) NUDT14BTKNUDT5SLC2A1SLC2A2
SCHEMBL19140501 0.71 SIGMAR1 (0.51) NUDT14BTKNUDT5SLC2A1SLC2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286812-A1 GPR119 Receptor Agonists ERICKSON SHAWN DAVID 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286812-A1 GPR119 Receptor Agonists GPR119, GPR27, GPR139 CYP3A4 1503/4885HRH4 555/4885MAP4K4 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.